We are committed to enabling you make things better. We love finding ways to create plant-based products with superior results. We team up with companies to make a big splash in the market.
You want to create something special that performs well, sells well and respects nature. With so many rules, costs, and competitors, it's tough to know which way to go.
Itaconix produces key ingredients for new generations of safer consumer products with superior performance and sustainability.
Every day we are motivated by the vision of biology powering the change humankind so desperately needs. Itaconix is leading that revolution.
We are building a large, profitable specialty ingredient company with safer products for the low carbon economy. Our growth rate has just begun to tap the potential of the addressable market.
Itaconix has entered a new era of development toward our long-term goal of becoming a large, highly profitable, capital-efficient specialty-ingredient company.
We know how to leverage our knowledge and expertise to offer insights that few others can.
Subscribe for updates and get insights sent directly to your inbox.
13 July 2018
Itaconix plc
(“Itaconix” or “the Company”)
Restoration of Trading in the Company’s Ordinary Shares on AIM
Itaconix’s shares were suspended from trading on AIM on 29 June 2018 pending clarification of its financial position. The Company announced on 12 July 2018 that it had raised circa £3.4 million (before expenses) (the “Fundraise”) by way of a placing of ordinary shares with certain institutional and other investors and by a subscription with certain US investors.
The Fundraise is conditional on, inter alia, shareholder approval at a general meeting to be held on 2 August 2018 (the “General Meeting”). The Company has received irrevocable undertakings to vote in favor of the resolutions to be proposed at the General Meeting in respect of, in aggregate, 3,625,445 ordinary shares, representing approximately 4.6% of the existing share capital. The Company has sufficient short-term working capital to continue trading until the General Meeting. In the event that shareholders do not approve the Fundraise at the General Meeting or that the net proceeds of the Fundraise are not received, then the Company would enter into some form of insolvency procedure because of its requirement for funding, as previously notified in the Company’s announcement of 29 June 2018.
Following receipt of the net proceeds of the Fundraise, which is expected to be on admission of the new ordinary shares to trading on AIM at 8.00 a.m. on 3 August 2018, Itaconix will have sufficient working capital for a period of at least 12 months. Consequently, the suspension in trading of the Company’s shares on AIM will be lifted at 7.30 a.m. on 16 July 2018.
For further information please contact:
Itaconix +44 (0) 1244 283 500
Kevin Matthews / Rob Cridland
N+1 Singer +44 (0) 207 496 3000
Richard Lindley / Jen Boorer (Corporate Finance)
Subscribe to our blog to get insights sent directly to your inbox.
